KLOW peptide FAQ: copper, colour and comparisons
Several names get compressed into KLOW. Here are the copper and ingredient distinctions that matter before judging the claims.
GHK-Cu vs KLOW
GHK-Cu is a copper-binding tripeptide. KLOW includes it alongside KPV, BPC-157 and TB-500. GHK-Cu accounts for 50 mg of the familiar 80 mg blend composition, which explains its large share by mass without establishing a greater clinical effect.
For questions about GHKCu and KLOW, the useful distinction is the preparation actually studied. The GHK skin review and the aged mouse-fibroblast experiment investigate particular forms of GHK and GHK-Cu, rather than the four-component blend.
Is KLOW peptide supposed to be blue?
The copper in GHK-Cu can give a reconstituted preparation a blue tint. The shade varies with concentration and preparation conditions. The copper-peptide literature discusses the complex, while the human-skin experiment measured copper delivery from a topical preparation.
For authenticity, I give that blue tint almost no weight. A visible tint cannot establish the amounts of the other ingredients, the complete contents or a treatment effect. Blue answers a much smaller question than “legit.”

KLOW vs BPC-157
BPC-157 is one ingredient in KLOW. It has its own rat tendon-healing research and a small human intravenous safety pilot. KLOW adds three more compounds with different research histories.
The larger ingredient list creates extra questions about interactions and exposure. Evidence that the blend improves on BPC-157 alone would require a direct comparison, which is absent from the research available here.
KLOW vs GLOW
The additional ingredient in KLOW is KPV. GLOW contains GHK-Cu, BPC-157 and TB-500. The ingredient article covers what KPV contributed in its own experiments. Community claims about one blend feeling better are anecdotal accounts rather than clinical comparison data.
Gut, skin and hair findings
KPV has intestinal-cell and mouse-colitis findings, and GHK-Cu has skin and matrix research. A simultaneous gut-and-skin benefit from KLOW remains unmeasured in controlled human blend research.
The human hair study examined GHK combined with 5-aminolevulinic acid in a topical formulation. Another paper tested AHK-Cu in human hair follicles and cells outside the body. AHK-Cu is a related copper peptide with a different amino-acid sequence. Neither finding earns the much broader label “KLOW hair results” for me.
KLOW and weight loss
The mixture's four ingredients are studied in repair and inflammatory contexts. None is a GLP-1 receptor agonist or an established weight-loss agent in this research record. The more specific questions about results, dosage and frequency, and side effects each have their own page.